Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
cryogenelab.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Cryogene

Cryogene operates a biostorage facility, specializing in the secure storage of biological specimens, materials and samples.

Cryogene Headquarter Location

9300 Kirby Drive Suite 200

Houston, Texas, 77054,

United States

(713) 664-1600

Latest Cryogene News

Cryoport expands into biostorage with Cryogene acquisition

May 23, 2019

Cryoport acquires Cryogene to gain access to the latter company’s 21,000-square-foot biostorage facility in Houston. The cold chain logistics firm for the life sciences industry has been looking to add storage services to its offering, Mark Sawicki, Cryoport’s CCO told us ​recently. The acquisition is structured as an asset purchase and, as stated, it is expected to be immediately accretive to Cryoport's earnings. The US facility provides storage of biological specimens, materials and samples for clients such as Merck, MD Anderson, Houston Methodist Hospital, Texas Children's Hospital, Mesoblast, Bellicum and Baylor University. The storage service for biological commodities covers a full range of temperatures, from cryogenic to controlled room temperature, and includes sample inventorying, data sample discrepancy resolution and accessioning samples into its validated data inventory software. The deal comes after Cryoport expanded the number of its clients recently, including adding Celularity ​to its clients roster. During the previous year, the company established multiple collaborations ​and boosted its revenue ​by becoming the exclusive distributor of Novartis’ Kymriah​ ​(tisagenlecleucel) and Kite’s Yescarta (axicabtagene ciloleucel), the two approved chimeric antigen receptor (CAR)-T therapies. Copyright - Unless otherwise stated all contents of this web site are © 2019 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.